Oman Health Exhibition & Conference — Muscat, 20–22 Sep 2027
Direct answer
The organiser exposes the 2026 exhibitor list and 2027 event proposition. It is prior-edition discovery evidence, not a complete confirmed 2027 list. The 2027 stand and registration-interest routes are live. Exhibiting, sponsorship and optional conference products require organiser confirmation. Qualify providers, distributors and procurement stakeholders by clinical or technology category Test medical-tourism, device, pharmaceutical or digital-health propositions against a named Omani route
- Editorial author
- Horizon Strategies
- Last verified in the editorial record
- Scope
- Oman · Healthcare & Life Sciences
| Fact or procedure | Recorded evidence | Authority and source | Checked |
|---|---|---|---|
| Recorded dates | 20–22 Sep 2027 | Original source | 2026-10-28 |
| Recorded city | Muscat | Original source | 2026-10-28 |
| Participation evidence | The 2027 stand and registration-interest routes are live. Exhibiting, sponsorship and optional conference products require organiser confirmation. | Original source | 2026-10-28 |
Limits and what this does not prove: The 5,000 attendee, 120 exhibitor and 10 pavilion figures are organiser propositions, not audited final attendance or a public buyer list. The available exhibitor evidence relates to 2026 and cannot be represented as the complete confirmed 2027 roster. Registration or a stand enquiry does not confirm access to a procurement owner, clinical decision-maker or government buyer. Device, pharmaceutical, data, professional-practice and distributor requirements must be checked with the relevant Omani authority for the specific offer.
Event evidence
The organiser exposes the 2026 exhibitor list and 2027 event proposition. It is prior-edition discovery evidence, not a complete confirmed 2027 list.
The 2027 stand and registration-interest routes are live. Exhibiting, sponsorship and optional conference products require organiser confirmation.
Qualify providers, distributors and procurement stakeholders by clinical or technology category
Test medical-tourism, device, pharmaceutical or digital-health propositions against a named Omani route
Separate public-patient engagement from professional procurement and partnership objectives
Questions before commitment
Is the objective clinical referral, product distribution, procurement or institutional partnership?
Which authority, registration and evidence requirements govern the offer?
Which named providers, distributors or public buyers should confirm meetings before travel?